Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;38(5):949-68.
doi: 10.1007/s00259-010-1687-7. Epub 2010 Dec 18.

In vivo imaging of immune cell trafficking in cancer

Affiliations
Review

In vivo imaging of immune cell trafficking in cancer

Luisa Ottobrini et al. Eur J Nucl Med Mol Imaging. 2011 May.

Abstract

Tumour establishment, progression and regression can be studied in vivo using an array of imaging techniques ranging from MRI to nuclear-based and optical techniques that highlight the intrinsic behaviour of different cell populations in the physiological context. Clinical in vivo imaging techniques and preclinical specific approaches have been used to study, both at the macroscopic and microscopic level, tumour cells, their proliferation, metastasisation, death and interaction with the environment and with the immune system. Fluorescent, radioactive or paramagnetic markers were used in direct protocols to label the specific cell population and reporter genes were used for genetic, indirect labelling protocols to track the fate of a given cell subpopulation in vivo. Different protocols have been proposed to in vivo study the interaction between immune cells and tumours by different imaging techniques (intravital and whole-body imaging). In particular in this review we report several examples dealing with dendritic cells, T lymphocytes and macrophages specifically labelled for different imaging procedures both for the study of their physiological function and in the context of anti-neoplastic immunotherapies in the attempt to exploit imaging-derived information to improve and optimise anti-neoplastic immune-based treatments.

PubMed Disclaimer

References

    1. J Biomed Opt. 2006 Jul-Aug;11(4):041119 - PubMed
    1. Nat Protoc. 2006;1(1):73-9 - PubMed
    1. J Natl Cancer Inst. 1996 Apr 3;88(7):461-2 - PubMed
    1. J Exp Med. 2006 Nov 27;203(12):2749-61 - PubMed
    1. Cancer Immunol Immunother. 2003 Jul;52(7):438-44 - PubMed

Publication types

Substances

LinkOut - more resources